-- Lucid Diagnostics (LUCD) said Friday that is has completed its underwritten direct offering of 18 million shares at $1 per share.
The company said the offering was anchored by a $15 million investment from a "fundamental" institutional investor with support from a large existing shareholder.
Lucid said it plans to use the net proceeds for working capital and general corporate purposes.
Price: $1.09, Change: $-0.01, Percent Change: -0.46%